1944. Tolerability and Safety of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Infants and Older Children in Global Studies

BACKGROUND: The 20-valent pneumococcal conjugate vaccine (PCV20), developed to expand protection against pneumococcal disease, is approved for adults in several countries and for pediatric use in the United States. Tolerability and safety data from PCV20 pediatric studies are described. METHODS: Fiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Flint, Laurence, McElwee, Kathleen, Ouedraogo, G Laissa, Tamimi, Noor, Kline, Mary J, Center, Kimberly J, Thompson, Allison, de Solom, Richard, Yamaji, Masako, Trammel, James, Lei, Lanyu, Peng, Yahong, Gruber, William C, Scott, Daniel, Watson, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677964/
http://dx.doi.org/10.1093/ofid/ofad500.098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677964/
http://dx.doi.org/10.1093/ofid/ofad500.098

Ejemplares similares